Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial.

Jönsson, Linus; Regnier, Stephane A; Kymes, Steven; Awad, Susanne F; Talon, Brian; Lee, Xin Ying; Goadsby, Peter J

Jönsson, Linus; Regnier, Stephane A; Kymes, Steven; Awad, Susanne F; Talon, Brian; Lee, Xin Ying; Goadsby, Peter J.

Afiliación

Jönsson L; Department for Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.
Regnier SA; H. Lundbeck A/S, Copenhagen, Denmark.
Kymes S; Lundbeck, LLC, Deerfield, IL, USA.
Awad SF; H. Lundbeck A/S, Copenhagen, Denmark.
Talon B; Lundbeck, LLC, Deerfield, IL, USA.
Lee XY; H. Lundbeck A/S, Copenhagen, Denmark.
Goadsby PJ; NIHR SLaM Clinical Research Facility at King's, and Headache Group, King's College London, London, United Kingdom.

Expert Rev Pharmacoecon Outcomes Res ; 23(7): 797-803, 2023.

Article en En | MEDLINE | ID: mdl-37256558

Asunto(s)

Trastornos Migrañosos; Humanos; Resultado del Tratamiento; Trastornos Migrañosos/tratamiento farmacológico; Método Doble Ciego

Palabras clave

eptinezumab; migraine; patient-reported outcome measures; quality of life; utility scores

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Migrañosos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google